lung cancer screening, trabectedin in soft tissue sarcoma, and more
Published 9 years ago • 590 plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
8:20
trabectedin in soft tissue sarcoma
-
8:14
efficacy and toxicities with trabectedin in sarcomas
-
1:25
dr. pautier on doxorubicin plus trabectedin in soft tissue sarcoma
-
3:16
dr. george d. demetri on trabectedin for sarcomas
-
4:49
current treatment landscape of soft tissue sarcoma
-
4:26
the role of trabectedin in sarcoma subtypes
-
0:55
jonathan trent on trabectedin for soft tissue sarcoma
-
1:04
how has the trabectedin extended access program benefited sarcoma patients?
-
9:43
soft tissue sarcoma: decisions following progression
-
7:57
fda approves mm-398, t-vec, and trabectedin, new pembrolizumab data, and more
-
1:38
dr. grignani discusses the safety profile of trabectedin in sarcoma
-
1:09
evaluating the activity of trabectedin and radiotherapy in sarcoma
-
3:40
management of oligometastases in soft-tissue sarcoma
-
2:13
ecco14: trabectedin for metastatic or advanced soft tissue sarcoma
-
2:13
dr. grignani on the role of trabectedin in sarcoma
-
1:30
dr. trent on sequencing trabectedin for patients with soft tissue sarcoma
-
5:23
olaratumab efficacy in soft-tissue sarcoma
-
0:51
dr. grignani on the patient population of trabectedin for sarcoma
-
8:02
sequencing decisions in soft tissue sarcoma